| Dr Paul Norman Weiss, MD | |
|
1433 N 1075 W Ste 104, Farmington, UT 84025-2746 | |
| (801) 298-1300 | |
| (801) 296-6199 |
| Full Name | Dr Paul Norman Weiss |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 1433 N 1075 W Ste 104, Farmington, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982604666 | NPI | - | NPPES |
| 107884400 | Medicaid | WY | |
| P00681089 | Other | UT | RR MEDICARE |
| 806753400 | Medicaid | ID | |
| 08459 | Medicaid | UT | |
| 923624 | Medicaid | AZ | |
| P00199640 | Other | UT | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0904X | Radiology - Nuclear Radiology | 174591-1205 (Utah) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 174591-1205 (Utah) | Primary |
| Entity Name | Moab Valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770513236 PECOS PAC ID: 2466361720 Enrollment ID: O20040114000346 |
News Archive
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Centene Corporation today announced its Superior HealthPlan, Inc. and its Superior HealthPlan Network have been tentatively awarded new contracts by the Texas Health and Human Services Commission.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 4 days ago
| Entity Name | Utah Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629076229 PECOS PAC ID: 1355394537 Enrollment ID: O20050228000845 |
News Archive
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Centene Corporation today announced its Superior HealthPlan, Inc. and its Superior HealthPlan Network have been tentatively awarded new contracts by the Texas Health and Human Services Commission.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 4 days ago
| Entity Name | Tooele Valley Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699004499 PECOS PAC ID: 2466624630 Enrollment ID: O20111012000146 |
News Archive
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Centene Corporation today announced its Superior HealthPlan, Inc. and its Superior HealthPlan Network have been tentatively awarded new contracts by the Texas Health and Human Services Commission.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 4 days ago
| Entity Name | Green River Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508533878 PECOS PAC ID: 5294123063 Enrollment ID: O20211027002062 |
News Archive
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Centene Corporation today announced its Superior HealthPlan, Inc. and its Superior HealthPlan Network have been tentatively awarded new contracts by the Texas Health and Human Services Commission.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Norman Weiss, MD Po Box 25488, Salt Lake City, UT 84125-0488 Ph: (800) 475-3698 | Dr Paul Norman Weiss, MD 1433 N 1075 W Ste 104, Farmington, UT 84025-2746 Ph: (801) 298-1300 |
News Archive
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.
Centene Corporation today announced its Superior HealthPlan, Inc. and its Superior HealthPlan Network have been tentatively awarded new contracts by the Texas Health and Human Services Commission.
The flame-retardant mixture known as "Firemaster 550" is an endocrine disruptor that causes extreme weight gain, early onset of puberty and cardiovascular health effects in lab animals, according to a new study spearheaded by researchers from North Carolina State University and Duke University.
› Verified 4 days ago
Dr. Cole Joseph Panushka, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 | |
Dr. Christopher J. Parr, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 | |
Dr. David Ray Dedrickson, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1433 N 1075 W, Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 | |
Dr. Jason Anthony Kirkham, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 | |
Colin David Jones, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 | |
Dr. Trenton Mcneil Wright, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 | |
Dr. Craig Michael Carpenter, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1433 N 1075 W Ste 104, Farmington, UT 84025 Phone: 801-298-1300 Fax: 801-296-6199 |